March 2, 2026 PARIS — EssilorLuxottica recently presented at two scientific forums in Hong Kong—the Collaborative Community on Ophthalmic Innovation (CCOI) Asia-Pacific Innovation...
Exploring H.A.L.T.* MAX Technology sponsored content December 16, 2025 By Dr. Björn Drobe, Director of Applied Myopia Research, R&D, EssilorLuxottica Since their...
sponsored content December 4, 2025 By Dr. Jason Shen, Director of Vision Science Research, North America, EssilorLuxottica Dr. Björn Drobe – Director,...
April 16, 2025 PARIS, France — At the 2025 China Optometry & Ophthalmology Conference (COOC), EssilorLuxottica shared the six-year data from the...
May 7, 2024 CHARENTON-LE-PONT, France — EssilorLuxottica has shared five-year data on its Stellest lenses at the Association for Research in Vision...
sponsored content February 1, 2024 Review of Myopia Management’s Editor-in-Chief John Sailer recently interviewed Dr. Björn Drobe, the Director of R&D Vision Science...
May 9, 2023 CHARENTON-LE-PONT, France — EssilorLuxottica presented its four-year clinical trial results for its Stellest lenses at the 2023 ARVO meeting....
April 29, 2022 CHARENTON-LE-PONT, France — Results of new research entitled “Progression of myopia with novel myopia control spectacle lenses“ will be...
September 21, 2021 CHARENTON-LE-PONT, France — Essilor is slated to present the results from its two-year clinical trial on Stellest lenses at the...